只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-15 2026-07-15 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 1,500 | US$0.86 | US$1,290.00 | 368,385 | SEC |
| 2026-07-14 2026-07-15 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 2,800 | US$0.88 | US$2,464.00 | 366,885 | SEC |
| 2026-07-10 2026-07-10 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 1,000 | US$0.94 | US$940.00 | 369,485 | SEC |
| 2026-07-09 2026-07-10 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 1,000 | US$0.90 | US$900.00 | 368,485 | SEC |
| 2026-07-08 2026-07-10 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,500 | US$0.97 | US$5,335.00 | 367,485 | SEC |
| 2026-07-08 2026-07-08 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,400 | US$0.96 | US$5,208.30 | 361,985 | SEC |
| 2026-06-23 2026-06-24 | BCDA BioCardia, Inc. | STERTZER SIMON H Director | 买入（P） | 39,000 | US$1.00 | US$39,000.00 | 166,338 | SEC |
| 2026-06-22 2026-06-24 | BCDA BioCardia, Inc. | STERTZER SIMON H Director | 买入（P） | 70,200 | US$0.92 | US$64,584.00 | 127,338 | SEC |
| 2026-06-18 2026-06-22 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 800 | US$0.96 | US$768.00 | 300,566 | SEC |
| 2026-06-17 2026-06-22 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 1,500 | US$0.85 | US$1,275.00 | 299,766 | SEC |
| 2026-06-09 2026-06-09 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,000 | US$0.85 | US$4,250.00 | 298,266 | SEC |
| 2026-05-20 2026-05-21 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 1,500 | US$0.92 | US$1,380.00 | 293,266 | SEC |
| 2026-05-19 2026-05-21 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 200 | US$0.95 | US$190.00 | 291,766 | SEC |
| 2026-05-18 2026-05-18 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,700 | US$0.92 | US$5,244.00 | 291,566 | SEC |
| 2026-05-15 2026-05-15 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,100 | US$1.02 | US$5,202.00 | 285,866 | SEC |
| 2026-04-29 2026-04-29 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 5,000 | US$1.11 | US$5,550.00 | 280,766 | SEC |
| 2026-04-21 2026-04-22 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 400 | US$1.23 | US$492.00 | 275,766 | SEC |
| 2026-04-20 2026-04-22 | BCDA BioCardia, Inc. | Altman Peter Director,Officer · President and CEO | 买入（P） | 600 | US$1.23 | US$738.00 | 275,366 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| BCDA | 54,467.9097 | 0 | 80,050.7087 | 68.04% | B, Q, N |